What is the NOAEL for Hydratropaldehyde?
Hydratropaldehyde has 45 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Also known as: 2-Phenylpropanal, Hydratropic aldehyde, Benzeneacetaldehyde, .alpha.-methyl-, Benzeneacetaldehyde, alpha-methyl-, Benzeneacetalaldehyde, alpha-methyl- (+15 more)
CAS 93-53-8
Hydratropaldehyde (CAS 93-53-8) is a chemical substance. Key regulatory status: REACH registered, 4 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
View cosmetic safety profile for Hydratropic Aldehyde (2-Phenylpropanal) →
Hydratropaldehyde is classified GHS CMR hazard (H315, H317, H319, H361) in the chemicals database but is restricted in EU cosmetics.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe | European Commission | Fl@vis |
| IFRA Transparency | IFRA | IFRA |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| consumer_product | P&G | Proctor & Gamble |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 44.5 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 4 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 28 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 38.2 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 37.9 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 40.8 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 0.875 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2.5 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 26.6 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 48.2 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 5.1 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 21.2 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 15.85 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 34.7 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 26 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 48.23 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 64.8 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 8JKX55PKZQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8JKX55PKZQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8JKX55PKZQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8JKX55PKZQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 112 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 167.6 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 195.1 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 3.449 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| 9.1 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| 14.3 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 14.29 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1296 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 1550 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 542.5 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| =2800 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =75 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| 10 | mg/kg bw/day | NOAEL | oral | rat | COSMOS_DB |
| =10 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =25 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =50 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_EFSA |
| =50 | mg/kg bw/day | NOAEL | oral: gavage | Rat | EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx |
| 500 | mg/kg bw/day | NOAEL | oral | rat | COSMOS_DB |
| 3 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
Showing 45 of 45 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Hydratropaldehyde | 202-255-5 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
ADI: No safety concern at current levels of intake when used as a flavouring agent mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Hydratropaldehyde has 45 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Hydratropaldehyde appears on 4 regulatory/inventory lists including Europe, IFRA Transparency, food_additive; Substances Added to Food (formerly EAFUS) (2/2019), and 1 more. Source: EPA CPDat.
Yes, Hydratropaldehyde is also indexed as a cosmetic ingredient under the name Hydratropic Aldehyde (2-Phenylpropanal). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Hydratropaldehyde is classified GHS CMR hazard (H315, H317, H319, H361) in the chemicals database but is restricted in EU cosmetics.
Hydratropaldehyde also appears in cosmetics, pharmaceutical, food safety, cannabis databases.